STOK · Stoke Therapeutics, Inc. · Share Buybacks
$26.29
-0.06 (-0.23%)
At close · Oct 30
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$1.68B
Shares
64.53M
Volume · Oct 30
1.86M
Avg daily vol (3M)
1.06M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | $150,000,000 | — | — | 10-Q , filed 2026-05-07 |
Key facts
CIK
1623526
CUSIP
86150R107
13F (30d)
32 filings
32 filers
Visit website
Investor relations